The New York Entrepreneur

Moderna shares fall despite promising data from cancer vaccine trial

Read Time:6 Second

Moderna’s mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Nikki Haley gets early support from wealthy donors while some remain on the sidelines
Next post Homebuilder sentiment rises in April, as builders grab near-record share of the market